Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release
NCT00492414 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2007-08-08
Summary
Panic disorder(PD)is a disabling psychiatric condition associated with significant impairment in psychosocial, occupational functioning and quality of life, as mentioned by mogotsi et al. So, most patients with panic disorder suffers from the consequences of the impairment in occupational function. This impairment is not only individual problem, but also social one. Since productivity is very important item required to employees, lost productive time among workers with psychiatric illness should be reduced by the proper management. But few data were reported in this field by now.
Conditions
- Panic Disorder
Interventions
- DRUG
-
Paroxetine CR
Sponsors & Collaborators
- collaborator INDUSTRY
-
Inje University
lead OTHER
Principal Investigators
-
Jong-Min Woo, Master · Seoul Paik Hospital, Inje University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- South Korea
Study Locations
More Related Trials
-
BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder
NCT00839397 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Study Of Paroxetine in Women and Men
NCT00264654 ·Status: COMPLETED ·Phase: PHASE3
-
Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
NCT00025740 ·Status: COMPLETED ·Phase: PHASE4
-
Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD
NCT02733614 ·Status: TERMINATED ·Phase: PHASE2
-
Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy
NCT00515996 ·Status: UNKNOWN
-
Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder
NCT01546896 ·Status: WITHDRAWN ·Phase: PHASE4
-
Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders
NCT00102427 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
NCT00736346 ·Status: UNKNOWN ·Phase: NA
-
Study Of Generalized Anxiety Disorder
NCT00135525 ·Status: COMPLETED ·Phase: PHASE2
-
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
NCT00658372 ·Status: TERMINATED ·Phase: PHASE3
-
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
NCT01704833 ·Status: COMPLETED ·Phase: NA
-
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
NCT00658762 ·Status: TERMINATED ·Phase: PHASE3
-
Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)
NCT00725725 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
NCT00031317 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine
NCT02852577 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Orexin in Human Panic Disorder
NCT02593682 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disorders(BASIS)
NCT04770454 ·Status: COMPLETED
-
Helping Adults With Obsessive-Compulsive Disorder Succeed at Work
NCT07124780 ·Status: RECRUITING ·Phase: NA
-
A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder
NCT05260541 ·Status: TERMINATED ·Phase: PHASE2
-
A New Intervention to Improve Function in Veterans With Anxiety and Depression
NCT06188923 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of Orexin Antagonism on Fear Extinction in PTSD
NCT06788522 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
NCT00540098 ·Status: COMPLETED ·Phase: PHASE4
-
Investigations of Factors Associated With Treatment Response and Prognosis in Anxiety Disorders
NCT06773585 ·Status: NOT_YET_RECRUITING
-
Social Anxiety Disorder Study Of Paroxetine
NCT00318669 ·Status: COMPLETED ·Phase: PHASE3
-
Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
NCT01376271 ·Status: COMPLETED